UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 291

Sortiert nach

The extracellular domain of Her2 in serum as a biomarker of breast cancer

Laboratory investigation, 2018-06, Vol.98 (6), p.696-707

2018

Volltextzugriff (PDF)

Understanding the Central Role of Citrate in the Metabolism of Cancer Cells and Tumors: An Update

International journal of molecular sciences, 2021-06, Vol.22 (12), p.6587

2021

Volltextzugriff (PDF)

First-line chemoimmunotherapy in metastatic breast carcinoma: combination of paclitaxel and IMP321 (LAG-3Ig) enhances immune responses and antitumor activity

Journal of translational medicine, 2010-07, Vol.8 (1), p.71-71, Article 71

2010

Volltextzugriff (PDF)

Maintenance capecitabine and bevacizumab versus bevacizumab alone after initial first-line bevacizumab and docetaxel for patients with HER2-negative metastatic breast cancer (IMELDA): a randomised, open-label, phase 3 trial

The lancet oncology, 2014-11, Vol.15 (12), p.1351-1360

2014

Volltextzugriff (PDF)

Preclinical Pharmacology of the Taxanes: Implications of the Differences

The oncologist (Dayton, Ohio), 2004-06, Vol.9 (S2), p.3-8

2004

Volltextzugriff (PDF)

Preference for subcutaneous or intravenous administration of trastuzumab in patients with HER2-positive early breast cancer (PrefHer): an open-label randomised study

The lancet oncology, 2013-09, Vol.14 (10), p.962-970

2013

Volltextzugriff (PDF)

An updated evaluation of serum sHER2, CA15.3, and CEA levels as biomarkers for the response of patients with metastatic breast cancer to trastuzumab-based therapies

PloS one, 2020-01, Vol.15 (1), p.e0227356-e0227356

2020

Volltextzugriff (PDF)

Neoadjuvant bevacizumab, trastuzumab, and chemotherapy for primary inflammatory HER2-positive breast cancer (BEVERLY-2): an open-label, single-arm phase 2 study

The lancet oncology, 2012-04, Vol.13 (4), p.375-384

2012

Volltextzugriff (PDF)

Association between overweight, obesity, and quality of life of patients receiving an anticancer treatment for prostate cancer: a systematic literature review

Health and quality of life outcomes, 2023-01, Vol.21 (1), p.11-11, Article 11

2023

Volltextzugriff (PDF)

Current challenges and unmet needs in treating patients with human epidermal growth factor receptor 2-positive advanced breast cancer

Breast (Edinburgh), 2022-12, Vol.66, p.145-156

2022

Volltextzugriff (PDF)

Local and Regional Breast Cancer Recurrences: Salvage Therapy Options in the New Era of Molecular Subtypes

Frontiers in oncology, 2018-04, Vol.8, p.112-112

2018

Volltextzugriff (PDF)

Pertuzumab and trastuzumab: the rationale way to synergy

Anais da Academia Brasileira de Ciências, 2016-01, Vol.88 Suppl 1 (suppl 1), p.565-577

2016

Volltextzugriff (PDF)

Safety and efficacy of adjuvant subcutaneous trastuzumab in human epidermal growth factor receptor 2-positive early breast cancer: Final results of the SafeHER study

Breast (Edinburgh), 2022-08, Vol.64, p.151-158

2022

Volltextzugriff (PDF)

Influence of chemotherapy on postural control and quality of life in women with gynaecological cancer: a protocol of a prospective observational study

BMJ open, 2022-09, Vol.12 (9), p.e061664

2022

Volltextzugriff (PDF)

Interaction between Radiation Therapy and Targeted Therapies in HER2-Positive Breast Cancer: Literature Review, Levels of Evidence for Safety and Recommendations for Optimal Treatment Sequence

Cancers, 2023-04, Vol.15 (8), p.2278

2023

Volltextzugriff (PDF)

Early HER2-positive breast cancers: time for a new revolution?

The lancet oncology, 2018-01, Vol.19 (1), p.12-13

Gligorov, Joseph

2018

Volltextzugriff (PDF)

Prognosis of triple-negative breast cancer associated with pregnancy: A propensity score-matched analysis from the French CALG (Cancer Associé à la Grossesse) network

Breast (Edinburgh), 2022-02, Vol.61, p.168-174

2022

Volltextzugriff (PDF)

Breast Cancer Management during the COVID 19 Pandemic: French Guidelines

European journal of breast health, 2020-07, Vol.16 (3), p.160-161

2020

Volltextzugriff (PDF)

Impact of coadministration of proton-pump inhibitors and palbociclib in hormone receptor-positive/HER2-negative advanced breast cancer

Breast (Edinburgh), 2024-08, Vol.76, p.103761, Article 103761

2024

Volltextzugriff (PDF)

Percutaneous Image-Guided Electrochemotherapy of Spine Metastases: Initial Experience

Cardiovascular and interventional radiology, 2019-12, Vol.42 (12), p.1806-1809

2019

Volltextzugriff (PDF)

Systemic therapy for early-stage breast cancer: learning from the past to build the future

Nature reviews. Clinical oncology, 2022-12, Vol.19 (12), p.763-774

2022

Volltextzugriff (PDF)

Feasibility, criterion and construct convergent validity of the 2-minute walk test and the 10-meter walk test in an oncological context

Heliyon, 2023-11, Vol.9 (11), p.e22180-e22180, Article e22180

2023

Volltextzugriff (PDF)

6th and 7th International consensus guidelines for the management of advanced breast cancer (ABC guidelines 6 and 7)

Breast (Edinburgh), 2024-08, Vol.76, p.103756, Article 103756

2024

Volltextzugriff (PDF)

Prognosis of HER2-positive pregnancy-associated breast cancer: Analysis from the French CALG (Cancer Associé à La Grossesse) network

Breast (Edinburgh), 2020-12, Vol.54, p.311-318

2020

Volltextzugriff (PDF)

1 – 25 von 291

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(270)
Mit Volltextzugriff
(243)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(153)
Life Sciences & Biomedicine
(149)
Humans
(130)
Oncology
(125)
Female
(99)
Breast Cancer
(71)
Breast Neoplasms - Drug Therapy
(56)
Life Sciences
(50)
Cancer
(49)
Middle Aged
(43)
Adult
(41)
Breast Neoplasms - Pathology
(41)
Aged
(40)
Chemotherapy
(39)
Tumors
(31)
Prognosis
(30)
Trastuzumab
(29)
Hematology, Oncology And Palliative Medicine
(28)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(24)
Antineoplastic Agents - Therapeutic Use
(22)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Bulletin Du Cancer
(60)
Journal Of Clinical Oncology
(24)
Breast
(18)
Cancer Research
(15)
Oncologie
(13)
The Journal Of High Energy Physics
(8)
Cancer
(7)
Critical Reviews In Oncology/hematology
(7)
Breast Cancer Research And Treatment
(6)
The Lancet Oncology
(6)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

The extracellular domain of Her2 in serum as a biomarker of breast cancer

Understanding the Central Role of Citrate in the Metabolism of Cancer Cells and Tumors: An Update

First-line chemoimmunotherapy in metastatic breast carcinoma: combination of paclitaxel and IMP321 (LAG-3Ig) enhances immune responses and antitumor activity

Maintenance capecitabine and bevacizumab versus bevacizumab alone after initial first-line bevacizumab and docetaxel for patients with HER2-negative metastatic breast cancer (IMELDA): a randomised, open-label, phase 3 trial

Preclinical Pharmacology of the Taxanes: Implications of the Differences

Preference for subcutaneous or intravenous administration of trastuzumab in patients with HER2-positive early breast cancer (PrefHer): an open-label randomised study

Bevacizumab plus chemotherapy versus chemotherapy alone as second-line treatment for patients with HER2-negative locally recurrent or metastatic breast cancer after first-line treatment with bevacizumab plus chemotherapy (TANIA): an open-label, randomised phase 3 trial

An updated evaluation of serum sHER2, CA15.3, and CEA levels as biomarkers for the response of patients with metastatic breast cancer to trastuzumab-based therapies

Neoadjuvant bevacizumab, trastuzumab, and chemotherapy for primary inflammatory HER2-positive breast cancer (BEVERLY-2): an open-label, single-arm phase 2 study

Association between overweight, obesity, and quality of life of patients receiving an anticancer treatment for prostate cancer: a systematic literature review

Current challenges and unmet needs in treating patients with human epidermal growth factor receptor 2-positive advanced breast cancer

Local and Regional Breast Cancer Recurrences: Salvage Therapy Options in the New Era of Molecular Subtypes

Pertuzumab and trastuzumab: the rationale way to synergy

Safety and efficacy of adjuvant subcutaneous trastuzumab in human epidermal growth factor receptor 2-positive early breast cancer: Final results of the SafeHER study

Influence of chemotherapy on postural control and quality of life in women with gynaecological cancer: a protocol of a prospective observational study

Interaction between Radiation Therapy and Targeted Therapies in HER2-Positive Breast Cancer: Literature Review, Levels of Evidence for Safety and Recommendations for Optimal Treatment Sequence

Early HER2-positive breast cancers: time for a new revolution?

Prognosis of triple-negative breast cancer associated with pregnancy: A propensity score-matched analysis from the French CALG (Cancer Associé à la Grossesse) network

Breast Cancer Management during the COVID 19 Pandemic: French Guidelines

Impact of coadministration of proton-pump inhibitors and palbociclib in hormone receptor-positive/HER2-negative advanced breast cancer

Percutaneous Image-Guided Electrochemotherapy of Spine Metastases: Initial Experience

Systemic therapy for early-stage breast cancer: learning from the past to build the future

Feasibility, criterion and construct convergent validity of the 2-minute walk test and the 10-meter walk test in an oncological context

6th and 7th International consensus guidelines for the management of advanced breast cancer (ABC guidelines 6 and 7)

Prognosis of HER2-positive pregnancy-associated breast cancer: Analysis from the French CALG (Cancer Associé à La Grossesse) network

Suchergebnisse filtern